MENU
+Compare
ACIU
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$2.85
Change
+$0.08 (+2.89%)
Capitalization
286.71M

ACIU AC Immune SA Forecast, Technical & Fundamental Analysis

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more

ACIU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ACIU with price predictions
Nov 28, 2025

Momentum Indicator for ACIU turns negative, indicating new downward trend

ACIU saw its Momentum Indicator move below the 0 level on November 10, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In of the 84 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ACIU turned negative on November 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

ACIU moved below its 50-day moving average on November 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACIU crossed bearishly below the 50-day moving average on November 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACIU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where ACIU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACIU advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACIU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACIU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.687) is normal, around the industry mean (27.312). P/E Ratio (0.000) is within average values for comparable stocks, (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (52.632) is also within normal values, averaging (321.020).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACIU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
ACIU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ACIU is expected to report earnings to rise 16.06% to -18 cents per share on March 12

AC Immune SA ACIU Stock Earnings Reports
Q4'25
Est.
$-0.19
Q3'25
Beat
by $0.03
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.01
Q4'24
Beat
by $0.03
The last earnings report on November 04 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 279.66K shares outstanding, the current market capitalization sits at 286.71M.
A.I. Advisor
published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHFHY11.00N/A
N/A
China Foods Ltd.
ALYAF1.20N/A
N/A
Alithya Group Inc.
AKRRF1.05N/A
N/A
Philly Shipyard ASA
BAESF21.16N/A
N/A
BAE Systems PLC
BTDPY10.35N/A
N/A
BARRATT REDROW PLC

ACIU and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with PDSB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
+1.09%
PDSB - ACIU
34%
Loosely correlated
+6.47%
KURA - ACIU
34%
Loosely correlated
-2.53%
LRMR - ACIU
33%
Poorly correlated
-12.11%
VRTX - ACIU
32%
Poorly correlated
+1.78%
ANRO - ACIU
32%
Poorly correlated
-1.82%
More